Abstract:Background: Maintaining intracellular equilibrium is essential for the viability of tumor cells, which tend to be particularly vulnerable to environmental stressors. Consequently, targeting the disruption of this homeostasis offers a promising approach for oncological treatments. LW-213, a novel derivative of wogonin, effectively induces apoptosis in cancer cells by initiating endoplasmic reticulum (ER) stress, although the precise molecular pathways involved remain intricate and multifaceted. Purpose: This research aimed to explore how LW-213 prompts apoptosis in non-small cell lung cancer (NSCLC) cells and to clarify the detailed mechanisms that govern this process. Methods: Various NSCLC cell lines were utilized to delineate the apoptotic effects induced by LW-213. Advanced methodologies, including RNA sequencing (RNA-seq), Western blotting (WB), immunofluorescence (IF), immunoprecipitation (IP), flow cytometry (Fc), real-time quantitative polymerase chain reaction (RT-qPCR), and electron microscopy, were employed to investigate the underlying molecular interactions. The efficacy and mechanistic action of LW-213 were also assessed in a xenograft model using nude mice. Results: We demonstrated that LW-213, a small molecule cationic amphiphilic drug (CAD), inhibited Niemann-Pick C1 (NPC1) function and induced lysosomal membrane damage, thereby activating the phosphoinositide-initiated membrane tethering and lipid transport (PITT) pathway. This activation promoted cholesterol transport from the ER to the lysosome, perpetuating a cholesterol-deficient state in the ER, including massive exocytosis of Ca2+ and activation of FAM134B-mediated reticulophagy. Ultimately, excessive reticulophagy induced lethal ER stress. Conclusions: In summary, our study elucidates an organelle domino reaction initiated by lysosome damage and a series of self-rescue mechanisms that eventually lead to irreversible lethal effects, revealing a potential drug intervention strategy.

LW-213 Induces G2/M Cell Cycle Arrest Through AKT/GSK3β/β-catenin Signaling Pathway in Human Breast Cancer Cells.

LW-213, a Newly Synthesized Flavonoid, Induces G2/M Phase Arrest and Apoptosis in Chronic Myeloid Leukemia

#2714, a Novel Active Inhibitor with Potent G2/M Phase Arrest and Antitumor Efficacy in Preclinical Models

Wogonin Induced G1 Cell Cycle Arrest by Regulating Wnt/β-catenin Signaling Pathway and Inactivating CDK8 in Human Colorectal Cancer Carcinoma Cells

LW-214, a Newly Synthesized Flavonoid, Induces Intrinsic Apoptosis Pathway by Down-Regulating Trx-1 in MCF-7 Human Breast Cells

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

LW-213, a derivative of wogonin, triggers reticulophagy-mediated cell death in NSCLC via lysosomal damage combined with NPC1 inhibition

Wogonin induces G<sub>1</sub> phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21<sup>Cip1</sup> in human cervical carcinoma HeLa cells

SKLB70326, a Novel Small-Molecule Inhibitor of Cell-Cycle Progression, Induces G0/G1 Phase Arrest and Apoptosis in Human Hepatic Carcinoma Cells

A novel cdk4/6 inhibitor wxj-111, against breast cancer through mediated cell-cycle arrest and apoptosis

Ginkgolide B Inhibits Lung Cancer Cells Promotion Via Beclin-1-dependent Autophagy

Effect of Magnetic Nanoparticles on Apoptosis and Cell Cycle Induced by Wogonin in Raji Cells

SKLB316, a Novel Small-Molecule Inhibitor of Cell-Cycle Progression, Induces G2/M Phase Arrest and Apoptosis in Vitro and Inhibits Tumor Growth in Vivo.

LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK–eIF2α–ATF4–CHOP axis

The Antitumor effect of wogonin, a lipoxygenase inhibitor, in both estrogen receptor-positive and -negative human breast cancers.

A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‐catenin Signaling

Design of Wogonin-Inspired Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitors with Potent in Vitro and in Vivo Antitumor Activity.

Induction of G2/M Cell Cycle Arrest via p38/p21Waf1/Cip1-Dependent Signaling Pathway Activation by Bavachinin in Non-Small-Cell Lung Cancer Cells

LL-202, a Newly Synthesized Flavonoid, Inhibits Tumor Growth Via Inducing G(2)/M Phase Arrest and Cell Apoptosis in MCF-7 Human Breast Cancer Cells in Vitro and in Vivo.

A Novel Derivative of Quinazoline, Wyk431 Induces G(2)/M Phase Arrest and Apoptosis in Human Gastric Cancer Bgc823 Cells Through the Pi3k/Akt Pathway

Novel CDK4/6 Lnhibitor, WXJ-8 -Exerts Anti-effects Through Cell Cycle in Breast Cancer